Clinical Trials Logo

Mildly Impaired Renal Function clinical trials

View clinical trials related to Mildly Impaired Renal Function.

Filter by:
  • None
  • Page 1

NCT ID: NCT00543075 Completed - Clinical trials for Normal Renal Function

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Start date: May 2006
Phase: Phase 1
Study type: Interventional

To characterize the pharmacokinetics of G3139 in subjects with normal, mildly impaired, and moderately impaired renal function who receive Genasense 3 mg/kg/day by continuous intravenous infusion for 2 days (48 hours).